Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Profit After Tax: 2010-2024

Historic Profit After Tax for CorMedix (CRMD) over the last 15 years, with Dec 2024 value amounting to -$17.9 million.

  • CorMedix's Profit After Tax rose 4009.63% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 495.00%. This contributed to the annual value of -$17.9 million for FY2024, which is 61.31% up from last year.
  • Per CorMedix's latest filing, its Profit After Tax stood at -$17.9 million for FY2024, which was up 61.31% from -$46.3 million recorded in FY2023.
  • CorMedix's 5-year Profit After Tax high stood at -$17.9 million for FY2024, and its period low was -$46.3 million during FY2023.
  • For the 3-year period, CorMedix's Profit After Tax averaged around -$31.3 million, with its median value being -$29.7 million (2022).
  • Per our database at Business Quant, CorMedix's Profit After Tax crashed by 56.02% in 2023 and then soared by 61.31% in 2024.
  • CorMedix's Profit After Tax (Yearly) stood at -$22.0 million in 2020, then fell by 28.07% to -$28.2 million in 2021, then decreased by 5.29% to -$29.7 million in 2022, then plummeted by 56.02% to -$46.3 million in 2023, then skyrocketed by 61.31% to -$17.9 million in 2024.